Literature DB >> 18472348

Effects of sub-anesthetic doses of ketamine on rats' spatial and non-spatial recognition memory.

N Pitsikas1, A Boultadakis, N Sakellaridis.   

Abstract

There are experimental evidences indicating that the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist ketamine impairs cognition and produces a series of schizophrenia-like symptoms in rodents (hyperactivity, stereotypies and ataxia). The present study was designed to investigate the effects of ketamine on rats' non-spatial and spatial recognition memory. For this purpose the object recognition and the object location task were selected. Pre- or post-training systemic administration of ketamine (0.3, 1 and 3 mg/kg; i.p.) in a dose-dependent manner disrupted animals' performance in both these recognition memory paradigms, suggesting that this compound affected pre- and post-training memory components. The current results indicate that the non-competitive NMDA antagonist ketamine may modulate either spatial or non-spatial recognition memory.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472348     DOI: 10.1016/j.neuroscience.2008.04.001

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

1.  Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems.

Authors:  Neil Dawson; Brian J Morris; Judith A Pratt
Journal:  Schizophr Bull       Date:  2011-11-22       Impact factor: 9.306

2.  The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.

Authors:  Nikolaos Pitsikas; Athina Markou
Journal:  Neuropharmacology       Date:  2014-05-20       Impact factor: 5.250

3.  Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats.

Authors:  Oliver Grimm; Natalia Gass; Wolfgang Weber-Fahr; Alexander Sartorius; Esther Schenker; Michael Spedding; Celine Risterucci; Janina Isabel Schweiger; Andreas Böhringer; Zhenxiang Zang; Heike Tost; Adam James Schwarz; Andreas Meyer-Lindenberg
Journal:  Psychopharmacology (Berl)       Date:  2015-07-18       Impact factor: 4.530

4.  Dose-dependent influence of sevoflurane anesthesia on neuronal survival and cognitive outcome after transient forebrain ischemia in Sprague-Dawley rats.

Authors:  Irina Lasarzik; Rüdiger R Noppens; Thorsten Wolf; Henrike Bauer; Clara Luh; Christian Werner; Kristin Engelhard; Serge C Thal
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

5.  Long-lasting effects of repeated ketamine administration in adult and adolescent rats.

Authors:  M L Shawn Bates; Keith A Trujillo
Journal:  Behav Brain Res       Date:  2019-04-26       Impact factor: 3.332

Review 6.  How Nox2-containing NADPH oxidase affects cortical circuits in the NMDA receptor antagonist model of schizophrenia.

Authors:  Xin Wang; António Pinto-Duarte; Terrence J Sejnowski; M Margarita Behrens
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

7.  The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.

Authors:  Aikaterini Trevlopoulou; Ntilara Touzlatzi; Nikolaos Pitsikas
Journal:  Psychopharmacology (Berl)       Date:  2015-12-19       Impact factor: 4.530

8.  Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks.

Authors:  Neil Dawson; Martin McDonald; Desmond J Higham; Brian J Morris; Judith A Pratt
Journal:  Neuropsychopharmacology       Date:  2014-02-04       Impact factor: 7.853

9.  GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.

Authors:  Lakshmi Rajagopal; Jeffrey S Burgdorf; Joseph R Moskal; Herbert Y Meltzer
Journal:  Behav Brain Res       Date:  2015-11-26       Impact factor: 3.332

10.  NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness.

Authors:  Tahir Hakami; Nigel C Jones; Elena A Tolmacheva; Julien Gaudias; Joseph Chaumont; Michael Salzberg; Terence J O'Brien; Didier Pinault
Journal:  PLoS One       Date:  2009-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.